|
G |
Ace |
angiotensin I converting enzyme |
decreases activity affects response to substance |
ISO |
benazepril results in decreased activity of ACE protein ACE gene polymorphism affects the susceptibility to benazepril |
CTD |
PMID:8359184 PMID:11007831 PMID:12652327 PMID:12848919 PMID:15498266 PMID:15555355 PMID:15788353 PMID:15793787 More...
|
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
affects response to substance increases response to substance multiple interactions |
ISO |
ACE2 gene SNP affects the susceptibility to benazepril ACE2 gene SNP results in increased susceptibility to benazepril [AGT gene polymorphism co-treated with ACE2 gene polymorphism] affects the susceptibility to benazepril |
CTD |
PMID:20559404 PMID:21449848 PMID:27121444 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
[irbesartan co-treated with benazepril] results in decreased expression of ACTA2 protein; benazepril inhibits the reaction [Doxorubicin results in increased expression of ACTA2 mRNA] |
CTD |
PMID:15149348 PMID:20493835 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
affects response to substance |
ISO |
ADRB2 protein polymorphism affects the susceptibility to benazepril |
CTD |
PMID:15554460 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
decreases expression |
EXP |
benazepril results in decreased expression of AGER mRNA; benazepril results in decreased expression of AGER protein |
CTD |
PMID:19018797 |
|
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Agt |
angiotensinogen |
decreases expression multiple interactions affects response to substance |
ISO EXP |
benazepril results in decreased expression of AGT protein; benazepril results in decreased expression of AGT protein modified form benazepril inhibits the reaction [Doxorubicin results in increased expression of AGT protein modified form]; benazepril inhibits the reaction [Particulate Matter results in increased expression of AGT protein modified form]; benazepril inhibits the reaction [Streptozocin results in increased expression of AGT protein modified form] AGT gene SNP affects the susceptibility to benazepril [AGT gene polymorphism co-treated with ACE2 gene polymorphism] affects the susceptibility to benazepril; [AGT gene polymorphism co-treated with AGTR1 gene polymorphism] affects the susceptibility to benazepril; [benazepril co-treated with Valsartan] results in decreased expression of AGT protein modified form; Valsartan inhibits the reaction [benazepril results in decreased expression of AGT protein] |
CTD |
PMID:10515446 PMID:11501062 PMID:11798627 PMID:12676074 PMID:17177138 PMID:17261659 PMID:18390891 PMID:19018797 PMID:20718632 PMID:20844835 PMID:21449848 More...
|
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions decreases expression |
EXP ISO |
benazepril inhibits the reaction [Doxorubicin results in increased expression of AGTR1 protein] benazepril results in decreased expression of AGTR1A mRNA; benazepril results in decreased expression of AGTR1A protein [AGT gene polymorphism co-treated with AGTR1 gene polymorphism] affects the susceptibility to benazepril |
CTD |
PMID:9596920 PMID:15157388 PMID:21449848 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
decreases expression multiple interactions |
ISO |
benazepril results in decreased expression of AMBP protein benazepril promotes the reaction [Losartan results in decreased expression of AMBP protein]; Losartan promotes the reaction [benazepril results in decreased expression of AMBP protein] |
CTD |
PMID:16303729 |
|
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
|
|
G |
Apob |
apolipoprotein B |
multiple interactions |
ISO |
[Valsartan co-treated with benazepril] results in decreased expression of APOB protein; fluvastatin promotes the reaction [[Valsartan co-treated with benazepril] results in decreased expression of APOB protein] |
CTD |
PMID:20671225 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Aqp1 |
aquaporin 1 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Glucose results in increased expression of AQP1 mRNA] |
CTD |
PMID:11510275 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp4 |
aquaporin 4 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Glucose results in increased expression of AQP4 mRNA] |
CTD |
PMID:11510275 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression |
EXP |
benazepril results in decreased expression of BAX protein |
CTD |
PMID:20026869 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression |
EXP |
benazepril results in increased expression of BCL2 protein |
CTD |
PMID:20026869 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
increases activity multiple interactions |
ISO EXP |
benazepril results in increased activity of BDKRB2 protein [icatibant results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to benazepril |
CTD |
PMID:15339989 PMID:16982965 |
|
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Estrogens deficiency results in increased expression of CCL2 protein]; benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL2 protein] |
CTD |
PMID:16284884 PMID:19553526 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Estrogens deficiency results in increased expression of CCL3 protein] |
CTD |
PMID:19553526 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] |
CTD |
PMID:16284884 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression |
EXP |
benazepril results in decreased expression of CCN2 mRNA |
CTD |
PMID:17121042 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Cd36 |
CD36 molecule |
increases expression |
EXP |
benazepril results in increased expression of CD36 mRNA |
CTD |
PMID:14871019 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
decreases expression multiple interactions |
EXP |
benazepril results in decreased expression of COL4A1 mRNA benazepril inhibits the reaction [Streptozocin results in increased expression of COL4A1 mRNA] |
CTD |
PMID:11798618 PMID:16191423 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Estrogens deficiency results in increased expression of CXCL1 protein] |
CTD |
PMID:19553526 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
affects response to substance |
ISO |
CYP11B2 gene polymorphism affects the susceptibility to benazepril |
CTD |
PMID:16765146 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Edn1 |
endothelin 1 |
decreases expression multiple interactions increases activity |
EXP |
benazepril results in decreased expression of EDN1 mRNA; benazepril results in decreased expression of EDN1 protein [Valsartan co-treated with benazepril] results in decreased expression of EDN1 protein benazepril results in increased activity of EDN1 protein |
CTD |
PMID:7528292 PMID:11136700 PMID:16191423 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
EXP |
benazepril results in increased expression of EGLN3 mRNA |
CTD |
PMID:14871019 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
EXP |
benazepril inhibits the reaction [Doxorubicin results in increased expression of FAS protein]; benazepril promotes the reaction [Valsartan inhibits the reaction [Doxorubicin results in increased expression of FAS protein]]; Valsartan promotes the reaction [benazepril inhibits the reaction [Doxorubicin results in increased expression of FAS protein]] |
CTD |
PMID:15315341 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
EXP |
benazepril inhibits the reaction [Doxorubicin results in increased expression of FASLG protein]; benazepril promotes the reaction [Valsartan inhibits the reaction [Doxorubicin results in increased expression of FASLG protein]]; Valsartan promotes the reaction [benazepril inhibits the reaction [Doxorubicin results in increased expression of FASLG protein]] |
CTD |
PMID:15315341 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression multiple interactions |
EXP |
benazepril results in decreased expression of FN1 mRNA; benazepril results in decreased expression of FN1 protein benazepril inhibits the reaction [Doxorubicin results in increased expression of FN1 protein]; benazepril inhibits the reaction [Streptozocin results in increased expression of FN1 mRNA] |
CTD |
PMID:10515446 PMID:11798618 PMID:16191423 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
benazepril results in increased expression of FOS mRNA |
CTD |
PMID:8539265 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
increases expression |
EXP |
benazepril results in increased expression of GOT2 mRNA |
CTD |
PMID:14871019 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Hgf |
hepatocyte growth factor |
increases expression |
EXP |
benazepril results in increased expression of HGF mRNA |
CTD |
PMID:16696918 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hspe1 |
heat shock protein family E (Hsp10) member 1 |
increases expression |
EXP |
benazepril results in increased expression of HSPE1 mRNA |
CTD |
PMID:14871019 |
|
NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Ethylene Glycol results in increased expression of IL6 protein] |
CTD |
PMID:16284884 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Glucose results in increased secretion of INS1 protein]; benazepril promotes the reaction [INS1 protein results in increased metabolism of Glucose] |
CTD |
PMID:7498292 PMID:9030901 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Kng1 |
kininogen 1 |
increases expression multiple interactions |
EXP |
benazepril results in increased expression of KNG1 protein modified form benazepril promotes the reaction [Valsartan results in increased expression of KNG1 protein modified form]; PD 123319 inhibits the reaction [benazepril promotes the reaction [Valsartan results in increased expression of KNG1 protein modified form]]; PD 123319 inhibits the reaction [Valsartan promotes the reaction [benazepril results in increased expression of KNG1 protein modified form]]; Valsartan promotes the reaction [benazepril results in increased expression of KNG1 protein modified form] |
CTD |
PMID:11509473 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases expression |
EXP |
benazepril results in increased expression of MAPK1 mRNA |
CTD |
PMID:14871019 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
EXP |
benazepril results in increased expression of ME1 mRNA |
CTD |
PMID:14871019 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP2 mRNA]; benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP2 protein]; benazepril inhibits the reaction [Streptozocin results in decreased expression of MMP2 mRNA]; benazepril inhibits the reaction [Streptozocin results in decreased expression of MMP2 protein] |
CTD |
PMID:16732983 PMID:19357873 PMID:20821936 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression increases activity multiple interactions |
ISO EXP |
benazepril results in decreased expression of MMP9 protein benazepril results in increased activity of MMP9 protein benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP9 mRNA]; benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP9 protein] |
CTD |
PMID:15339989 PMID:19357873 PMID:20981132 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
affects response to substance |
ISO |
MTHFR gene polymorphism affects the susceptibility to benazepril; MTHFR gene SNP affects the susceptibility to benazepril |
CTD |
PMID:16081343 PMID:20445573 |
|
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
affects response to substance |
ISO |
MTR gene SNP affects the susceptibility to benazepril; MTR protein polymorphism affects the susceptibility to benazepril |
CTD |
PMID:15148588 PMID:20445573 |
|
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
EXP |
benazepril results in increased expression of MYC mRNA |
CTD |
PMID:8539265 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myh6 |
myosin heavy chain 6 |
multiple interactions |
EXP |
[Valsartan co-treated with benazepril] results in increased expression of MYH6 mRNA |
CTD |
PMID:11136700 |
|
NCBI chr15:28,418,120...28,442,316
Ensembl chr15:28,417,616...28,441,720
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
decreases expression |
EXP |
benazepril results in decreased expression of NCF1 mRNA |
CTD |
PMID:19018797 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Ethylene Glycol results in increased expression of NFKB1 protein] |
CTD |
PMID:16284884 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
benazepril inhibits the reaction [Streptozocin results in decreased expression of NFKBIA mRNA] |
CTD |
PMID:17900838 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression |
EXP |
benazepril results in decreased expression of NOS2 mRNA; benazepril results in decreased expression of NOS2 protein |
CTD |
PMID:16191423 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions decreases expression |
EXP |
[Valsartan co-treated with benazepril] results in decreased expression of NPPA mRNA benazepril results in decreased expression of NPPA mRNA |
CTD |
PMID:8763405 PMID:11136700 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions decreases expression |
EXP |
[Valsartan co-treated with benazepril] results in decreased expression of NPPB mRNA benazepril results in decreased expression of NPPB mRNA |
CTD |
PMID:11136700 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
benazepril inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
EXP |
benazepril results in decreased expression of PCNA protein |
CTD |
PMID:17121042 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
increases expression |
EXP |
benazepril results in increased expression of PDK4 mRNA |
CTD |
PMID:14871019 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pla2g5 |
phospholipase A2, group V |
decreases expression |
EXP |
benazepril results in decreased expression of PLA2G5 mRNA |
CTD |
PMID:14871019 |
|
NCBI chr 5:151,041,339...151,109,433
Ensembl chr 5:151,041,340...151,062,658
|
|
G |
Plau |
plasminogen activator, urokinase |
multiple interactions |
EXP |
benazepril inhibits the reaction [Streptozocin results in increased expression of PLAU mRNA] |
CTD |
PMID:15322501 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
multiple interactions |
EXP |
benazepril inhibits the reaction [Streptozocin results in increased expression of PLAUR mRNA] |
CTD |
PMID:15322501 |
|
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plg |
plasminogen |
increases activity multiple interactions |
ISO |
benazepril results in increased activity of PLG protein FR 173657 inhibits the reaction [benazepril results in increased activity of PLG protein] |
CTD |
PMID:15339989 |
|
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
|
|
G |
Prcp |
prolylcarboxypeptidase |
affects response to substance |
ISO |
PRCP gene SNP affects the susceptibility to benazepril |
CTD |
PMID:20079160 |
|
NCBI chr 1:146,931,487...146,983,891
Ensembl chr 1:146,930,561...146,984,530
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases expression decreases phosphorylation |
EXP |
benazepril inhibits the reaction [Doxorubicin results in increased expression of RELA mRNA]; benazepril inhibits the reaction [Streptozocin results in increased expression of RELA mRNA] benazepril results in decreased expression of RELA mRNA; benazepril results in decreased expression of RELA protein benazepril results in decreased phosphorylation of RELA protein |
CTD |
PMID:15157388 PMID:17900838 PMID:19018797 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ren |
renin |
increases expression increases activity multiple interactions |
ISO EXP |
benazepril results in increased expression of REN protein benazepril results in increased activity of REN protein [benazepril co-treated with Valsartan] results in increased activity of REN protein |
CTD |
PMID:1316404 PMID:10836730 PMID:11501062 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
decreases expression |
EXP |
benazepril results in decreased expression of RSAD2 mRNA |
CTD |
PMID:14871019 |
|
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
|
|
G |
Serpine1 |
serpin family E member 1 |
decreases expression multiple interactions |
ISO EXP |
benazepril results in decreased expression of SERPINE1 mRNA; benazepril results in decreased expression of SERPINE1 protein FR 173657 inhibits the reaction [benazepril results in decreased expression of SERPINE1 mRNA] benazepril inhibits the reaction [Streptozocin results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:15322501 PMID:15339989 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinh1 |
serpin family H member 1 |
increases expression |
EXP |
benazepril results in increased expression of SERPINH1 mRNA |
CTD |
PMID:14871019 |
|
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
|
|
G |
Slc15a1 |
solute carrier family 15 member 1 |
multiple interactions |
ISO |
benazepril inhibits the reaction [SLC15A1 protein results in increased uptake of glycylsarcosine] |
CTD |
PMID:18713951 |
|
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
|
|
G |
Slc15a2 |
solute carrier family 15 member 2 |
multiple interactions |
ISO EXP |
benazepril inhibits the reaction [SLC15A2 protein results in increased uptake of glycylsarcosine] |
CTD |
PMID:18713951 |
|
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
|
|
G |
Smad2 |
SMAD family member 2 |
affects expression multiple interactions |
EXP |
benazepril affects the expression of SMAD2 mRNA; benazepril affects the expression of SMAD2 protein [benazepril co-treated with irbesartan] affects the expression of SMAD2 mRNA; [benazepril co-treated with irbesartan] affects the expression of SMAD2 protein |
CTD |
PMID:16635409 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
affects expression multiple interactions |
EXP |
benazepril affects the expression of SMAD3 mRNA; benazepril affects the expression of SMAD3 protein [benazepril co-treated with candesartan] results in decreased expression of SMAD3 protein; [benazepril co-treated with irbesartan] affects the expression of SMAD3 mRNA; [benazepril co-treated with irbesartan] affects the expression of SMAD3 protein |
CTD |
PMID:16635409 PMID:19487956 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Snrpn |
small nuclear ribonucleoprotein polypeptide N |
decreases expression |
EXP |
benazepril results in decreased expression of SNRPN mRNA |
CTD |
PMID:14871019 |
|
NCBI chr 1:111,101,327...111,123,400
Ensembl chr 1:111,101,329...111,123,634
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
[benazepril co-treated with Valsartan] results in increased expression of SOD1 protein |
CTD |
PMID:20445533 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
decreases expression |
EXP |
benazepril results in decreased expression of SPP1 mRNA |
CTD |
PMID:11867951 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression multiple interactions affects expression |
ISO EXP |
benazepril results in decreased expression of TGFB1 protein benazepril results in decreased expression of TGFB1 mRNA; benazepril results in decreased expression of TGFB1 protein [benazepril co-treated with candesartan] results in decreased expression of TGFB1 protein; [benazepril co-treated with Irbesartan] affects the expression of TGFB1 mRNA; benazepril inhibits the reaction [Doxorubicin results in increased expression of TGFB1 mRNA]; benazepril inhibits the reaction [Doxorubicin results in increased expression of TGFB1 protein]; benazepril inhibits the reaction [Streptozocin results in increased expression of TGFB1 mRNA]; benazepril inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein] benazepril affects the expression of TGFB1 mRNA [benazepril co-treated with Valsartan] results in decreased expression of TGFB1 protein |
CTD |
PMID:10515446 PMID:11798627 PMID:11867951 PMID:16191423 PMID:16409969 PMID:16523407 PMID:16635409 PMID:17177138 PMID:18390891 PMID:19018797 PMID:19487956 PMID:20493835 PMID:20844835 More...
|
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Streptozocin results in increased expression of TGFBR1 mRNA]; benazepril inhibits the reaction [Streptozocin results in increased expression of TGFBR1 protein] |
CTD |
PMID:11798618 |
|
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
decreases expression multiple interactions |
EXP |
benazepril results in decreased expression of TIMP1 mRNA; benazepril results in decreased expression of TIMP1 protein benazepril inhibits the reaction [Doxorubicin results in increased expression of TIMP1 mRNA]; benazepril inhibits the reaction [Doxorubicin results in increased expression of TIMP1 protein] |
CTD |
PMID:11867951 PMID:18471418 PMID:19357873 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
EXP |
benazepril inhibits the reaction [Streptozocin results in increased expression of TIMP2 mRNA]; benazepril inhibits the reaction [Streptozocin results in increased expression of TIMP2 protein] |
CTD |
PMID:16732983 PMID:20821936 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tlr4 |
toll-like receptor 4 |
decreases expression |
ISO |
benazepril results in decreased expression of TLR4 protein |
CTD |
PMID:20981132 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression multiple interactions |
ISO EXP |
benazepril results in decreased expression of TNF protein [benazepril co-treated with Amlodipine] results in decreased expression of TNF protein |
CTD |
PMID:16775501 PMID:20981132 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
decreases expression |
EXP |
benazepril results in decreased expression of VCAM1 mRNA; benazepril results in decreased expression of VCAM1 protein |
CTD |
PMID:19018797 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
benazepril inhibits the reaction [Streptozocin results in increased expression of VEGFA protein] |
CTD |
PMID:20844835 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|